RY 175.93 0.091% SHOP 158.44 0.4056% TD 79.29 0.2656% ENB 60.325 0.3076% BN 86.12 0.0348% TRI 227.16 0.1852% CNQ 47.27 0.5317% CP 105.91 0.2271% CNR 156.29 0.1474% BMO 133.39 0.1351% BNS 79.77 0.3144% CSU 4705.0 -0.3509% CM 90.74 0.0441% MFC 44.885 0.3914% ATD 82.63 0.194% NGT 59.24 0.6114% TRP 68.36 0.633% SU 55.7 0.3423% WCN 272.35 0.5612% L 182.05 0.7081%
.jpg)
Onconova Therapeutics Inc.
Onconova Therapeutics, Inc. is a biopharmaceutical business in the clinical stages that focuses on finding and creating treatments for cancer patients. It uses medicines that are molecularly targeted and intended to block particular biological pathways that support the growth of cancer cells. It has two clinical-stage programmes: narazaciclib (ON 123300), a multi-targeted kinase inhibitor used to treat solid tumours and haematological malignancies either alone or in conjunction with existing anti-cancer treatments; and rigosertib, used to treat solid tumours either alone or in combination.
Technical Daily Chart:
Markets are trading in a highly volatile zone currently due to certain macroeconomic issues and geopolitical tensions prevailing. Therefore, it is prudent to follow a cautious approach while investing.
Note 1: Past performance is not a reliable indicator of future performance.
Note 2: The reference date for all price data, currency, technical indicators, support, and resistance levels is March 23, 2023. The reference data in this report has been partly sourced from REFINITIV.
Note 3: Investment decisions should be made depending on an individual's appetite for upside potential, risks, holding duration, and any previous holdings. An 'Exit' from the stock can be considered if the Target Price mentioned as per the Valuation and or the technical levels provided has been achieved and is subject to the factors discussed above.
Note 4: The report publishing date is as per the Pacific Time Zone.
Disclaimer
The advice given by Kalkine Canada Advisory Services Inc. and provided on this website is general information only and it does not take into account your investment objectives, financial situation and the particular needs of any particular person. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. The website www.kalkine.ca is published by Kalkine Canada Advisory Services Inc. The link to our Terms & Conditions has been provided please go through them. On the date of publishing this report (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.
CA 
AU
UK
US
NZ
Please wait processing your request...